Lipid Nanoparticle Aerosolization for mRNA Lung-based Gene Treatment | Nanobot Inhalation for Genetic Modification

In the rapidly evolving realm of technology, nanorobotics is making a significant stride, with potential applications that span across various fields, including medicine and biosecurity.

Conventional microchips have proven to be ineffective when attached to colloids. However, a promising alternative has emerged in the form of two-dimensional electronic materials, such as graphene and transition-metal dichalcogenides. These materials can be used instead, providing a new avenue for miniaturised technology.

One of the most intriguing aspects of nanorobotics is its versatility. These tiny machines can function as both sensors and receiver-delivery devices. Their controllability enables their directed activity in biological organisms, opening up possibilities for targeted delivery and monitoring.

The intersection of nanotechnology and synthetic biology could lead to more effective capabilities to deliver new, potent synthetic microbes or chem-bio hybrids. These agents could be customised to create novel agents that are not recognised by existing regulatory bodies or anticipated by public health and biosecurity operations.

This convergence of technologies has not gone unnoticed by researchers. Institutions such as MIT, Harvard, and various nanotechnology and biomedical laboratories have investigated the weaponisation of aerosolized mRNA lipid nanoparticles and microrobots for gene therapy and biosensory applications. While the potential benefits of targeted delivery and monitoring are apparent, ethical and safety implications are also a cause for concern.

A researcher has made a controversial claim, asserting that nano and micro robots are already in everyone's blood. This assertion, however, is yet to be substantiated by peer-reviewed research.

Darkfield live blood analysis of C19 uninjected blood has shown self-assembly of nanobots into polymer networks. A video, taken at AM Medical LLC clinic in 2023, shows micro robots maneuvering through C19 uninjected blood and self-assembling polymers. Another video, taken at the same clinic in 2024 by the researcher, corroborates these findings.

The potential use of these robots for diagnostic purposes in the body is promising. They could search for signs of inflammation or other disease indicators, revolutionising the field of medicine.

However, the possibility of these nanobots being used as stand-alone weapons or force multipliers for extant biochemical agents is a cause for concern. Aerosolized nanobots could potentially bypass the current Biological and Toxin Weapons Convention or Chemical Weapons Convention, as they can be partially or fully autonomous and store information with the potential to identify or affect specific biological targets.

The development of cell-sized robots with tiny electronic circuits made of two-dimensional materials, which can be attached to colloids and remain operational in air or water, further underscores the potential of this technology. These robots can be powered by nanowatts with subvolt voltages, making them incredibly energy-efficient.

The debate surrounding the use of nanorobotics in medicine and biosecurity continues, with questions about ethics, safety, and the potential for misuse at the forefront. As research progresses, it is crucial that these concerns are addressed to ensure the responsible development and deployment of this transformative technology.